Search clinical trials for: CC ECIG Condition
Total 2479 results
-
T.C. ORDU ÜNİVERSİTESİCompletedAnesthesia; Functional | Postoperative Analgesia
-
M.D. Anderson Cancer CenterYukiguni Maitake Company Ltd.Terminated
-
Actavis Inc.Completed
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedHematopoietic and Lymphoid Cell Neoplasm | Lymphoma | Leukemia | Plasma Cell Myeloma | B-Cell Non-Hodgkin Lymphoma | T-Cell Non-Hodgkin LymphomaUnited States
-
AmgenCompletedPlaque PsoriasisSpain, United States, Canada, Germany, Denmark, France, Italy, Switzerland, Austria
-
AmgenCompletedPhase 3b Safety and Efficacy Study of Apremilast to Treat Moderate to Severe Plaque-plaque PsoriasisPsoriasis | Psoriatic ArthritisUnited States, Canada, United Kingdom, Australia, Hungary, Belgium, Netherlands, Germany, Czechia, Estonia, Latvia
-
National Cancer Institute (NCI)CompletedRefractory Differentiated Thyroid Gland Carcinoma | Unresectable Thyroid Gland Carcinoma | Refractory Thyroid Gland Papillary Carcinoma | Refractory Thyroid Gland Follicular Carcinoma | Refractory Thyroid Gland Hurthle Cell CarcinomaUnited States, Canada
-
Yale UniversityNational Institute on Drug Abuse (NIDA); VA Office of Research and DevelopmentCompletedMarijuana Abuse | CannabisUnited States
-
Cancer Research UKUnknown
-
University of ChicagoRecruiting
-
OncotherapeuticsTerminated
-
CelgeneCompletedMyelofibrosis | Myeloid Metaplasia | Myelofibrosis With Myeloid MetaplasiaUnited States, Italy, United Kingdom, Austria, Spain
-
National Cancer Institute (NCI)CompletedRecurrent Mantle Cell LymphomaUnited States
-
National Cancer Institute (NCI)CompletedAnemia | Thrombocytopenia | Chronic Lymphocytic Leukemia | Recurrent Small Lymphocytic Lymphoma | Prolymphocytic Leukemia | Refractory Chronic Lymphocytic LeukemiaUnited States
-
Assistance Publique - Hôpitaux de ParisMinistry of Health, FranceCompleted
-
University of California, IrvineRecruitingBreast Cancer | Metastatic Breast Cancer | HER2-negative Breast Cancer | Hormone Receptor-positive Breast CancerUnited States
-
Medical University of South CarolinaCompleted
-
Washington University School of MedicineNational Cancer Institute (NCI); National Institutes of Health (NIH); LasMed LLCCompletedChemotherapy-induced Peripheral NeuropathyUnited States
-
I.M. Sechenov First Moscow State Medical UniversityCompletedTumors of the Central Nervous System | Childhood Cancer SurvivorsRussian Federation
-
AstraZenecaParexelCompletedLung CancerCanada, Denmark, Italy, Spain, Belgium, Korea, Republic of, Brazil, China, Taiwan, Australia, Austria, United Kingdom, Sweden, Argentina, Saudi Arabia, Ireland
-
Desmond Tutu HIV CentreNational Institute of Mental Health (NIMH); Bill and Melinda Gates Foundation; University of WashingtonUnknown
-
Cancer Research UKRoyal Marsden NHS Foundation Trust; Hoffmann-La Roche; University of Manchester; University of BirminghamRecruitingSolid Tumor | Haematological MalignancyUnited Kingdom
-
Zagazig UniversityCompleted
-
University GhentRecruitingHearing Loss, Sensorineural | Speech IntelligibilityBelgium
-
Memorial Sloan Kettering Cancer CenterRecruitingLymphoma | Lymphoma, B-Cell | Multiple Myeloma | High-grade B-cell Lymphoma | Refractory B-Cell Lymphoma | DLBCL NOSUnited States
-
Ankara Diskapi Training and Research HospitalUnknownIPACK Block Multimodal Analgesia | Postoperative NRS ScoresTurkey
-
Chestnut Hill Health SystemCompleted
-
Johns Hopkins UniversityUniversity of Maryland; American Academy of Otolaryngology-Head and Neck Surgery...RecruitingPostoperative Pain | Opioid UseUnited States
-
Dokuz Eylul UniversityCompleted
-
The Catholic University of KoreaUnknownVitiligo | Treatment | Corticosteroid | Intralesional InjectionKorea, Republic of
-
Steven P. Treon, MD, PhDCelgene CorporationTerminatedWaldenstrom's MacroglobulinemiaUnited States
-
National Cancer Institute (NCI)CompletedStage II Multiple Myeloma | Stage III Multiple Myeloma | Refractory Multiple MyelomaUnited States
-
National Cancer Institute (NCI)TerminatedKidney Cancer | Renal CancerUnited States
-
CelgeneRecruitingRelapsed or Refractory Multiple MyelomaUnited States, Australia, Italy, China, Spain, Germany, Romania, Korea, Republic of, Japan, United Kingdom, Czechia, Finland, France, Greece, Argentina, Belgium, Austria, Portugal, Israel, Poland, Brazil, Turkey, Canada, Ireland, New Zealand and more
-
Beth ChristianGenentech, Inc.; CelgeneActive, not recruitingRecurrent Marginal Zone Lymphoma | Recurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Recurrent Burkitt Lymphoma | Recurrent Follicular Lymphoma | Refractory Follicular Lymphoma | Refractory Burkitt Lymphoma | Grade 1 Follicular Lymphoma | Grade 2 Follicular Lymphoma | Grade 3a Follicular Lymphoma and other conditionsUnited States
-
Mayo ClinicNational Cancer Institute (NCI)Active, not recruitingPlasma Cell MyelomaUnited States
-
Georgetown UniversityNational Cancer Institute (NCI)TerminatedChronic Lymphocytic Leukemia | Small Lymphocytic LymphomaUnited States
-
Mayo ClinicNational Cancer Institute (NCI)WithdrawnExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Burkitt Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Adult Diffuse Mixed Cell Lymphoma | Recurrent Adult Diffuse Small Cleaved Cell Lymphoma and other conditions
-
University of Colorado, DenverTerminatedRefractory Plasma Cell MyelomaUnited States
-
University Magna GraeciaCompletedPolycystic Ovary Syndrome | AnovulationItaly
-
Virginia Clinical Research, Inc.Celgene CorporationUnknownLichen PlanusUnited States
-
Mayo ClinicRecruiting
-
M.D. Anderson Cancer CenterGenentech, Inc.; Seagen Inc.RecruitingMetastatic Solid Tumor | Brain MetastasesUnited States
-
Oslo University HospitalVestre Viken Hospital Trust; University Hospital of North Norway; Ostfold Hospital... and other collaboratorsRecruitingCancer MetastaticNorway
-
Duke UniversityMillennium Pharmaceuticals, Inc.TerminatedLymphoma, FollicularUnited States
-
Alice MimsNational Cancer Institute (NCI)Recruiting
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedPlasma Cell Myeloma | Hematopoietic Cell Transplantation RecipientUnited States
-
AstraZenecaTigerMedCompleted
-
The First Affiliated Hospital of Xiamen UniversityUnknown
-
National Cancer Institute (NCI)Not yet recruiting